Open Menu Close Menu

Accelerating Discovery


Located in Parkville, Melbourne – the epicentre of Australian medical research and innovation, we are a venture-discovery company led by an outstanding team of experts.

We manage a portfolio of investee early-stage biopharmaceutical companies developing platform technologies and delivering first in class/best in class small molecule drugs for indications including oncology and chronic inflammatory diseases. We’re able to accelerate development by sourcing and providing access to capital, expertise and R&D capacity.

Success Stories

  • SYNthesis med chem CRO was acquired by Viva Biotech (Shanghai) Ltd. for USD 80 Million in 2020.

  • SYNthesis Research has completed three license deals with major Pharma partners since 2016 through its diverse investments in risk-managed drug discovery & development.




All news


Get in Touch